5 min
BMS schizophrenia drug shines, Novartis axes jobs, Lilly compounding suit dismissed [The good, the bad, the ugly] Off Script: A Pharma Manufacturing Podcast
-
- Næringslivsnyheter
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — BMS schizophrenia drug shines in phase 3 trialThe bad — Novartis to axe 680 jobsThe ugly — Lilly compounding suit dismissed
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — BMS schizophrenia drug shines in phase 3 trialThe bad — Novartis to axe 680 jobsThe ugly — Lilly compounding suit dismissed
5 min